Arrowhead Current Deferred Revenue from 2010 to 2024

ARWR Stock  USD 24.88  0.21  0.85%   
Arrowhead Pharmaceuticals Current Deferred Revenue yearly trend continues to be relatively stable with very little volatility. Current Deferred Revenue is likely to drop to about 946.1 K. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2001-09-30
Previous Quarter
866 K
Current Value
55.4 M
Quarterly Volatility
40.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Arrowhead Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arrowhead main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.1 M, Interest Expense of 20 M or Selling General Administrative of 79.1 M, as well as many exotic indicators such as Price To Sales Ratio of 10.19, Dividend Yield of 0.0 or PTB Ratio of 4.8. Arrowhead financial statements analysis is a perfect complement when working with Arrowhead Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Arrowhead Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Arrowhead Pharmaceuticals Technical models . Check out the analysis of Arrowhead Pharmaceuticals Correlation against competitors.
To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.

Latest Arrowhead Pharmaceuticals' Current Deferred Revenue Growth Pattern

Below is the plot of the Current Deferred Revenue of Arrowhead Pharmaceuticals over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Arrowhead Pharmaceuticals' Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arrowhead Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Current Deferred Revenue10 Years Trend
Slightly volatile
   Current Deferred Revenue   
       Timeline  

Arrowhead Current Deferred Revenue Regression Statistics

Arithmetic Mean19,561,130
Geometric Mean976,277
Coefficient Of Variation186.04
Mean Deviation27,232,032
Median946,105
Standard Deviation36,392,362
Sample Variance1324.4T
Range111.1M
R-Value0.33
Mean Square Error1271.9T
R-Squared0.11
Significance0.23
Slope2,676,852
Total Sum of Squares18541.7T

Arrowhead Current Deferred Revenue History

2024946.1 K
2023995.9 K
2022866 K
202174.1 M
2020111.1 M
201919.3 M
201877.8 M

About Arrowhead Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Arrowhead Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Arrowhead Pharmaceuticals investors use historical funamental indicators, such as Arrowhead Pharmaceuticals's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Arrowhead Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Arrowhead Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Arrowhead Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Arrowhead Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Arrowhead Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue995.9 K946.1 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Arrowhead Pharmaceuticals is a strong investment it is important to analyze Arrowhead Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Arrowhead Pharmaceuticals' future performance. For an informed investment choice regarding Arrowhead Stock, refer to the following important reports:
Check out the analysis of Arrowhead Pharmaceuticals Correlation against competitors.
To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Arrowhead Stock analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Money Managers
Screen money managers from public funds and ETFs managed around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.098
Earnings Share
(4.23)
Revenue Per Share
0.319
Quarterly Revenue Growth
(0.94)
Return On Assets
(0.32)
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrowhead Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.